| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |





From the Division of Specific Organs Cancer,* Pediatric Oncology Division, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do; and the Department of Pathology, Tumor Immunity Medical Research Center and Cancer Research Institute,
and the Department of Pharmacology,
Seoul National University College of Medicine, Chongno-gu, Seoul, Korea
Lipid rafts/caveolae are membrane platforms for signaling molecules that regulate various cellular functions, including cell survival. To better understand the role of rafts in tumor progression and therapeutics, we investigated the effect of raft disruption on cell viability and compared raft levels in human cancer cell lines versus their normal counterparts. Here, we report that cholesterol depletion using methyl-ß cyclodextrin caused anoikis-like apoptosis, which in A431 cells involved decreased raft levels, Bcl-xL down-regulation, caspase-3 activation, and Akt inactivation regardless of epidermal growth factor receptor activation. Cholesterol repletion replenished rafts on the cell surface and restored Akt activation and cell viability. Moreover, the breast cancer and the prostate cancer cell lines contained more lipid rafts and were more sensitive to cholesterol depletion-induced cell death than their normal counterparts. These results indicate that cancer cells contain increased levels of rafts and suggest a potential use of raft-modulating agents as anti-cancer drugs.
This article has been cited by other articles:
![]() |
W. Martinet and G. R.Y. De Meyer Autophagy in Atherosclerosis: A Cell Survival and Death Phenomenon With Therapeutic Potential Circ. Res., February 13, 2009; 104(3): 304 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fromigue, Z. Hamidouche, and P. J. Marie Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion J. Biol. Chem., November 7, 2008; 283(45): 30549 - 30556. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao and J. Zhang Spatiotemporal Analysis of Differential Akt Regulation in Plasma Membrane Microdomains Mol. Biol. Cell, October 1, 2008; 19(10): 4366 - 4373. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ristorcelli, E. Beraud, P. Verrando, C. Villard, D. Lafitte, V. Sbarra, D. Lombardo, and A. Verine Human tumor nanoparticles induce apoptosis of pancreatic cancer cells FASEB J, September 1, 2008; 22(9): 3358 - 3369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fedida-Metula, S. Elhyany, S. Tsory, S. Segal, M. Hershfinkel, I. Sekler, and D. Fishman Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells Carcinogenesis, August 1, 2008; 29(8): 1546 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Montero, A. Morales, L. Llacuna, J. M. Lluis, O. Terrones, G. Basanez, B. Antonsson, J. Prieto, C. Garcia-Ruiz, A. Colell, et al. Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma Cancer Res., July 1, 2008; 68(13): 5246 - 5256. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fromigue, Z. Hamidouche, and P. J. Marie Statin-Induced Inhibition of 3-Hydroxy-3-Methyl Glutaryl Coenzyme A Reductase Sensitizes Human Osteosarcoma Cells to Anticancer Drugs J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 595 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Chinni, H. Yamamoto, Z. Dong, A. Sabbota, R. D. Bonfil, and M. L. Cher CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone Mol. Cancer Res., March 1, 2008; 6(3): 446 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuehnle, A. Crameri, R. E. Kalin, P. Luciani, S. Benvenuti, A. Peri, F. Ratti, M. Rodolfo, L. Kulic, F. L. Heppner, et al. Prosurvival Effect of DHCR24/Seladin-1 in Acute and Chronic Responses to Oxidative Stress Mol. Cell. Biol., January 15, 2008; 28(2): 539 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Palmer, R. Mahen, E. Schnell, M. B.A. Djamgoz, and E. Aydar Sigma-1 Receptors Bind Cholesterol and Remodel Lipid Rafts in Breast Cancer Cell Lines Cancer Res., December 1, 2007; 67(23): 11166 - 11175. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Adam, N. K. Mukhopadhyay, J. Kim, D. Di Vizio, B. Cinar, K. Boucher, K. R. Solomon, and M. R. Freeman Cholesterol Sensitivity of Endogenous and Myristoylated Akt Cancer Res., July 1, 2007; 67(13): 6238 - 6246. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brusselmans, L. Timmermans, T. Van de Sande, P. P. Van Veldhoven, G. Guan, I. Shechter, F. Claessens, G. Verhoeven, and J. V. Swinnen Squalene Synthase, a Determinant of Raft-associated Cholesterol and Modulator of Cancer Cell Proliferation J. Biol. Chem., June 29, 2007; 282(26): 18777 - 18785. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Siddiqui, K. A. Harvey, G. P. Zaloga, and W. Stillwell Modulation of Lipid Rafts by {Omega}-3 Fatty Acids in Inflammation and Cancer: Implications for Use of Lipids During Nutrition Support Nutr Clin Pract, February 1, 2007; 22(1): 74 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Calzolari, C. Raggi, S. Deaglio, N. M. Sposi, M. Stafsnes, K. Fecchi, I. Parolini, F. Malavasi, C. Peschle, M. Sargiacomo, et al. TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway J. Cell Sci., November 1, 2006; 119(21): 4486 - 4498. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |